NUTRITIONAL INSULIN OR GLP-1 RECEPTOR AGONIST: CROSSROADS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS

Endocr Pract. 2017 Nov;23(11):1357-1358. doi: 10.4158/EP-2017-0135.
No abstract available

Publication types

  • Comment

MeSH terms

  • Blood Glucose
  • Diabetes Mellitus, Type 2*
  • Glucagon-Like Peptide 1
  • Glucagon-Like Peptide-1 Receptor
  • Humans
  • Hypoglycemic Agents
  • Insulin*

Substances

  • Blood Glucose
  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents
  • Insulin
  • Glucagon-Like Peptide 1